(Q33313240)

25 July 2017

Expression of 15-PGDH is downregulated by COX-2 in gastric cancer (English)

1 reference

25 July 2017

Zhenxiong Liu

1

1 reference

25 July 2017

Xin Wang

2

1 reference

25 July 2017

Yuanyuan Lu

3

1 reference

25 July 2017

Shuang Han

4

1 reference

25 July 2017

Faming Zhang

5

1 reference

25 July 2017

Huihong Zhai

6

1 reference

25 July 2017

Ting Lei

7

1 reference

25 July 2017

Jie Liang

8

1 reference

25 July 2017

Jun Wang

9

1 reference

25 July 2017

Kaichun Wu

10

1 reference

25 July 2017

Daiming Fan

11

1 reference

25 July 2017

language of work or name

English

0 references

publication date

3 January 2008

1 reference

25 July 2017

1 reference

25 July 2017

29

1 reference

25 July 2017

1219-1227

1 reference

25 July 2017

6

1 reference

Chemoprevention of gastric cancer by celecoxib in rats.

25 July 2017

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

Nicotine promotes gastric tumor growth and neovascularization by activating extracellular signal-regulated kinase and cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

The anti-cancer effect of COX-2 inhibitors on gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

Celecoxib could reverse the hypoxia-induced Angiopoietin-2 upregulation in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

Survivin depletion preferentially reduces the survival of activated K-Ras-transformed cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

Inhibition of gastric cancer-associated angiogenesis by antisense COX-2 transfectants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

Lymphovascular invasion is associated with poor survival in gastric cancer: an application of gene-expression and tissue array techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

Cyclooxygenase-2: a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

Cyclooxygenase‐2 and gastric carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

Chemopreventive effect of celecoxib in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

The role of cyclooxygenase-2 and prostaglandins in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

Involvement of cyclooxygenase-2--prostaglandin E2 pathway in interleukin-8 production in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

The cyclooxygenase-2-mediated prostaglandin signaling is causally related to epithelial carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

NAD+-linked 15-hydroxyprostaglandin dehydrogenase: structure and biological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

15-hydroxyprostaglandin dehydrogenase (15-PGDH) and lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

15-Hydroxyprostaglandin-dehydrogenase is involved in anti-proliferative effect of non-steroidal anti-inflammatory drugs COX-1 inhibitors on a human medullary thyroid carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

Cellular prion protein promotes invasion and metastasis of gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: a review and report of personal experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

PGE2 inhibits apoptosis in human adenocarcinoma Caco-2 cell line through Ras-PI3K association and cAMP-dependent kinase A activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

Expression of microsomal prostaglandin E synthase-1 in intestinal type gastric adenocarcinoma and in gastric cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

Regulation of the immune response by prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

Prostaglandin E2 increases growth and motility of colorectal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

Prostaglandins and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM297

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGM297

1 reference

25 July 2017

1 reference